Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

FibermarX Radiopaque Tissue Marker

K-Number: K190155 · 2019-02-27

Decision Date2019-02-27
Product CodeIYE
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

FibermarX Radiopaque Tissue Marker is the device name listed in this FDA 510(k) record. The listed applicant is Viscus Biologics, LLC. It received FDA 510(k) clearance on 2019-02-27 under 510(k) number K190155. The device is classified under product code IYE. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the FibermarX Radiopaque Tissue Marker?

FibermarX Radiopaque Tissue Marker is a medical device that received FDA 510(k) clearance on 2019-02-27. The listed applicant is Viscus Biologics, LLC. The 510(k) number is K190155.

When did FibermarX Radiopaque Tissue Marker receive FDA 510(k) clearance?

FibermarX Radiopaque Tissue Marker received FDA 510(k) clearance on 2019-02-27, under 510(k) number K190155.

Who is the listed applicant for FibermarX Radiopaque Tissue Marker?

The FDA 510(k) record lists Viscus Biologics, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for FibermarX Radiopaque Tissue Marker?

The FDA product code for FibermarX Radiopaque Tissue Marker is IYE.

Other records listing Viscus Biologics, LLC as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: IYE)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.